| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/19/2011 | CN101951900A Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres |
| 01/19/2011 | CN101951897A Use of amidoxime carboxylic acid esters and N-hydroxyguanidine carboxylic acid esters for producing prodrugs |
| 01/19/2011 | CN101951884A Compositions and methods for the treatment of bladder cancer |
| 01/19/2011 | CN101948859A shRNA expression vector expressed by specificity inhibitor SET protein, construction method and application thereof |
| 01/19/2011 | CN101948858A RNA (Ribose Nucleic Acid) interference recombination vector of SET (Patient SE Translocation) genes and establishment method and application thereof |
| 01/19/2011 | CN101948841A Epitope sequences |
| 01/19/2011 | CN101948694A Rare earth upconversion nano crystal/silver difunctional composite nano material, preparation method thereof and application thereof in cancer detection and treatment |
| 01/19/2011 | CN101948566A Multifunctional polymer for resisting fungi and cancers and performing cell imaging and preparation method thereof |
| 01/19/2011 | CN101948544A FAT10 gene siRNA recombination analogue virus as well as preparation method and application thereof |
| 01/19/2011 | CN101948541A Compositions and methods for the diagnosis and treatment of tumor |
| 01/19/2011 | CN101948540A Preparation of novel anti-EGFR human source antibody MIL27 and application thereof |
| 01/19/2011 | CN101948539A IL-18 binding proteins |
| 01/19/2011 | CN101948508A Tumor-resistance CTL (Cytotoxic T Lymphocyte) epitope peptide derived from PIWIL2 and application thereof |
| 01/19/2011 | CN101948507A Novel anti-cancer medicaments using NGR(NO2) as targeting carrier, preparation thereof and use thereof |
| 01/19/2011 | CN101948500A New derivative of camptothecin 20-site coupled bile acid |
| 01/19/2011 | CN101948488A Ruthenium-selenium coordination compound and application thereof in preparing fluorescent probe and antineoplastic medicine |
| 01/19/2011 | CN101948475A Isoflavone derivate-chromene (chroman) oxazines compound, preparation method and application thereof |
| 01/19/2011 | CN101948473A New NEO-clerodane diterpenoid compound and application thereof |
| 01/19/2011 | CN101948472A Novel staurosporine analogue and preparation method and applications thereof |
| 01/19/2011 | CN101948467A Thiazoleamide compound and use thereof for the preparation of anti-malignant tumor medicines |
| 01/19/2011 | CN101948464A 3,4,6-triaryl-(1,3)-oxazine-2-ketone compound as well as preparation method and application thereof |
| 01/19/2011 | CN101948458A Baicalein derivatives with antitumor activity and application thereof in medicines |
| 01/19/2011 | CN101948456A Rhizoma zedoariae inner ester derivant with antitumor activity and preparation method thereof |
| 01/19/2011 | CN101948453A Novel NEO-clerodane typed diterpene compound and application thereof |
| 01/19/2011 | CN101948429A 1-methyl-7H-indene[1, 2-b]quinolinetrifluoromesylate-7-(4-dimethylamino) benzyl alkene derivant and preparation thereof |
| 01/19/2011 | CN101948428A 1-methyl-5H-indene (1,2-b) pyridine trifluoromethanesulfonic salt-5-(4-dimethylamino group) benzylidene derivative and preparation method thereof |
| 01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
| 01/19/2011 | CN101948381A Novel antineoplastic compound |
| 01/19/2011 | CN101947310A Adrenocorticotropic hormone analogs and related methods |
| 01/19/2011 | CN101947292A Chinese medicinal oral preparation for treating uterine cancer, cervical cancer and ovarian cancer |
| 01/19/2011 | CN101947283A Formula of moxibustion Chinese medicinal composition for treating cancer and preparation method |
| 01/19/2011 | CN101947256A Medicament for treating cancer and preparation method thereof |
| 01/19/2011 | CN101947255A Magnoliabiloba extract and extracting method thereof |
| 01/19/2011 | CN101947251A Method for preparing chickpea isoflavone microcapsules |
| 01/19/2011 | CN101947244A Disinfection pill |
| 01/19/2011 | CN101947243A Mushroom poison paste |
| 01/19/2011 | CN101947238A Pharmaceutical composition for treating cancer and application thereof |
| 01/19/2011 | CN101947232A Use of cactus pear fruit polysaccharides in preparation of medicaments or health-care products |
| 01/19/2011 | CN101947225A Anticancer application of alkaloid |
| 01/19/2011 | CN101947215A Application of flavonoid compound in tangerine peel to preparation of medicament for inhibiting angiogenesis |
| 01/19/2011 | CN101947208A Fludarabine phosphate composition for injection and preparation method thereof |
| 01/19/2011 | CN101947204A Neo-gambogic acid SLN (solid lipid nanoparticle) and preparation method thereof |
| 01/19/2011 | CN101633660B Novel abietane-type diterpene compound as well as preparation method and application thereof |
| 01/19/2011 | CN101560213B Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application |
| 01/19/2011 | CN101485626B Aqueous solution containing coenzyme Q10 nano granule and preparation method thereof |
| 01/19/2011 | CN101455702B Traditional Chinese medicinal preparation for treating cancer |
| 01/19/2011 | CN101445543B Gorgonian polyhydroxy sterol, preparation method and application thereof |
| 01/19/2011 | CN101391042B Traditional Chinese medicine extract for suppressing lung cancer A549 cell proliferation and preparation method thereof |
| 01/19/2011 | CN101386818B Extract of sea fungal culture and preparation method and application thereof |
| 01/19/2011 | CN101362731B Heterocyclic compounds and methods of use |
| 01/19/2011 | CN101343247B Cyclohexenone extract of antrodia camphorata |
| 01/19/2011 | CN101323646B Phellinus polysaccharide II having antineoplastic activity, extraction and separation method thereof |
| 01/19/2011 | CN101322681B Method for preparing nano micelle formulation of anthracene nucleus antineoplastic antibiotic |
| 01/19/2011 | CN101296928B Compounds and compositions as protein kinase inhibitors |
| 01/19/2011 | CN101292974B Pharmaceutical use of diacetyl diphenyl sulphone heptane in preventing and controlling chronic marrow-derived leukocythemia |
| 01/19/2011 | CN101292685B Health care edible oil |
| 01/19/2011 | CN101244067B Application of 23-hydroxyl radical betulic acid in preparing reversal agent multidrug resistance of cancer cell |
| 01/19/2011 | CN101235070B Oleanane triterpene with A ring containing double bond and C ring containing conjugated ketenes, and use thereof |
| 01/19/2011 | CN101234205B High molecule adriamycin bonding medicine nano capsule with targeting function and preparation thereof |
| 01/19/2011 | CN101224299B Preparing method of compounds capable of inducing tumor cell apoptosis |
| 01/19/2011 | CN101215305B Glucosyl thiourea heterocyclic compound and its synthetic method and application in antineoplastic |
| 01/19/2011 | CN101214320B Medicament for treating leukemia and preparation thereof |
| 01/19/2011 | CN101160290B 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 01/19/2011 | CN101156952B DC cell targeted carrier, nanometer corpuscle and preparation method |
| 01/19/2011 | CN101156848B Application of porphyrin class in preparation of sound motivation therapy medicine |
| 01/19/2011 | CN101117354B Esterified pine pollen polysaccharide and preparation method and use thereof |
| 01/19/2011 | CN101103031B Pyrrolo pyrimidine derivatives useful for treating proliferative diseases |
| 01/19/2011 | CN101011419B Propolis preparation and its preparation method |
| 01/18/2011 | US7872142 Coumarin derivatives useful as TNFα inhibitors |
| 01/18/2011 | US7872133 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 01/18/2011 | US7872125 1-Methyl,3-((1,3-dichloro-phenyl)-carbonylamino-(1-carboxy- eth-1,2-ylene)-(1,4-phenylene)-)quinazolin-2,4-dione; inhibiting the adhesion of VCAM-1 (vascular cellular adhesion molecules-1) to alpha-4 integrin; antiinflammatory agents; cardiovascular disorders; multiple sclerosis; antiarthritic agent |
| 01/18/2011 | US7872112 comprising rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A),deoxyhypusine synthase (DHS) nucleic acids and polypeptides; human cytomegalovirus immediate-early promoter/enhancer |
| 01/18/2011 | US7872094 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD) |
| 01/18/2011 | US7872052 2-(2-iodophenyl)-6,7-dimethoxybenzo[d][1,3]oxazin-4-one for treating atopic dermatitis, contact dermatitis, eczema, psoriasis, acne, epidermal hyperkeratosis, acanthosis, epidermal inflammation, dermal inflammation and pruritus |
| 01/18/2011 | US7872029 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 01/18/2011 | US7872018 Compounds and methods for kinase modulation, and indications therefor |
| 01/18/2011 | US7872014 Anaplastic lymphoma kinase modulators and methods of use |
| 01/18/2011 | US7872000 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors |
| 01/18/2011 | US7871819 recombinant vector comprising a sequence encoding a heterologous polypeptide inserted between E4 and E3 transcription units of an ovine adenovirus genome; directing expression of a coding sequence in a cell; cancer |
| 01/18/2011 | US7871786 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase; antitumor agents, anticancer agents |
| 01/18/2011 | US7871765 Composition having antitumor effect |
| 01/18/2011 | US7871763 gene expression; probes, primers, antibodies |
| 01/18/2011 | US7871644 Mixture of drug, aminoacrylate polymer and acid |
| 01/18/2011 | US7871627 Gram positive bacteria preparations for the treatment of disease comprising an immune dysregulation |
| 01/18/2011 | US7871620 Immunoliposomes that optimize internationalization into target cells |
| 01/18/2011 | US7871617 Von Willebrand's factor (VWC); transforming growth factors, bone morphongenic proteins as cofactors; monoclonal antibodies for use in diagnosis and treatment of diabetes, hypertension, hyperglycemia and congestive heart failure |
| 01/18/2011 | US7871606 Use of stimulated peripheral-blood mononuclear cells for the treatment of cancerous diseases |
| 01/18/2011 | CA2576549C Stable pegylated interferon formulation |
| 01/18/2011 | CA2568590C Propane-1,3-dione derivative or salt thereof useful as gnrh receptor antagonist |
| 01/18/2011 | CA2566160C Pyrrolopyrimidine derivatives useful in cancer treatment |
| 01/18/2011 | CA2493310C 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition |
| 01/18/2011 | CA2475630C N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids |
| 01/18/2011 | CA2452386C Granulates containing liposoluble substances and a process for the preparation thereof |
| 01/18/2011 | CA2451504C A process for the isolation of a major harmful oxidant from cigarette smoke |
| 01/18/2011 | CA2436825C Process for the crystallization of (r)- or (s)-lansoprazole |
| 01/18/2011 | CA2408501C Melphalan derivatives and their use as cancer chemotherapeutic drugs |
| 01/18/2011 | CA2384502C Use of .alpha.-linolenic acid metabolites for treatment or prevention of cancer |
| 01/18/2011 | CA2383737C Muc-1 derived peptides |
| 01/18/2011 | CA2380537C An oncolytic adenovirus |
| 01/18/2011 | CA2331460C Heterocyclic inhibitors of p38 |